Selective loss of dopaminergic neurons in the substantia nigra of Pitx3-deficient aphakia mice

被引:201
作者
Hwang, DY
Ardayfio, P
Kang, UJ
Semina, EV
Kim, KS
机构
[1] Harvard Univ, Sch Med, Neurosci Program, Belmont, MA 02478 USA
[2] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA
[3] Med Coll Wisconsin, Dept Pediat, Human & Mol Genet Ctr, Milwaukee, WI 53226 USA
[4] Harvard Univ, Sch Med, Mol Neurobiol Labs, McLean Hosp,Program Neurosci, Belmont, MA 02478 USA
来源
MOLECULAR BRAIN RESEARCH | 2003年 / 114卷 / 02期
关键词
dopamine; DA neuron development; A9; neurons; Substantia nigra pas compacta; A10; ventral tegmental area; ak mice; Pitx3; Parkinson's disease;
D O I
10.1016/S0169-328X(03)00162-1
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Dopaminergic (DA) neurons in the ventral midbraim nuclei, substantia nigra pars compacta (SNc, A9) and ventral tegmental area (VTA, A10), play important roles in the control of movement, emotion, cognition, and reward related behavior. Although several transcription factors have been shown to be critical for midbrain DA neuron development, there has been no report of factor(s) that differentially regulate individual DA neuronal groups. Based on its highly restricted expression in the SNc and VTA in the brain, we hypothesize that the homeobox transcription factor Pitx3 may critically regulate the development of ventral midbrain DA neurons. In this study, we report that in Pitx3-deficient ak/ak mice, DA neurons in the SNc and the nigrostriatal pathway fail to develop properly, and DA levels are reduced to 10% of the wild type mice in the dorsal striatum. On the contrary, A10 neurons are intact in ak/ak mice and DA levels within their projection areas are not affected. This region-specific defect was already evident in newborn mice, suggesting that the defect had occurred during the early stages of mouse development. Taken together, our results indicate that Pitx3 is the first known transcription factor that may critically and selectively control proper development of A9 DA neurons and the nigrostriatal pathway. This observation is of great importance in understanding the mechanisms of DA neuron development and may also help us to understand the mechanism of selective degeneration of A9 DA neurons in Parkinson's disease and to devise novel therapeutic approaches for the disorder. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:123 / 131
页数:9
相关论文
共 31 条
  • [1] BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5
  • [2] Cell replacement therapies for central nervous system disorders
    Björklund, A
    Lindvall, O
    [J]. NATURE NEUROSCIENCE, 2000, 3 (06) : 537 - 544
  • [3] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [4] Dopamine biosynthesis is selectively abolished in substantia nigra ventral tegmental area but not in hypothalamic neurons in mice with targeted disruption of the Nurr1 gene
    Castillo, SO
    Baffi, JS
    Palkovits, M
    Goldstein, DS
    Kopin, IJ
    Witta, J
    Magnuson, MA
    Nikodem, VM
    [J]. MOLECULAR AND CELLULAR NEUROSCIENCE, 1998, 11 (1-2) : 36 - 46
  • [5] Biochemical and anatomical characterization of forepaw adjusting steps in rat models of Parkinson's disease: Studies on medial forebrain bundle and striatal lesions
    Chang, JW
    Wachtel, SR
    Young, D
    Kang, UJ
    [J]. NEUROSCIENCE, 1999, 88 (02) : 617 - 628
  • [6] Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons
    Chung, S
    Sonntag, KC
    Andersson, T
    Bjorklund, LM
    Park, JJ
    Kim, DW
    Kang, UJ
    Isacson, O
    Kim, KS
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 2002, 16 (10) : 1829 - 1838
  • [7] A proposed test battery and constellations of specific behavioral paradigms to investigate the behavioral phenotypes of transgenic and knockout mice
    Crawley, JN
    Paylor, R
    [J]. HORMONES AND BEHAVIOR, 1997, 31 (03) : 197 - 211
  • [8] Neuroprotective and neurorestorative strategies for Parkinson's disease
    Dawson, TM
    Dawson, VL
    [J]. NATURE NEUROSCIENCE, 2002, 5 (Suppl 11) : 1058 - 1061
  • [9] Specification of catecholaminergic and serotonergic neurons
    Goridis, C
    Rohrer, H
    [J]. NATURE REVIEWS NEUROSCIENCE, 2002, 3 (07) : 531 - 541
  • [10] A high-efficiency synthetic expression selectively promoter that drives transgene in noradrenergic neurons
    Hwang, DY
    Carlezon, WA
    Isacson, O
    Kim, KS
    [J]. HUMAN GENE THERAPY, 2001, 12 (14) : 1731 - 1740